Praxis Precision Medicines to report Q2 2026 earnings on August 6

Seeking Alpha··Read original
2▲0 ▼0Impact / 5
Summary · why it matters

Praxis Precision Medicines is scheduled to announce its second-quarter 2026 earnings results on Thursday, August 6th, before market open. The consensus earnings per share estimate is negative $3.69, representing an 11.5% decline year-over-year, while the consensus revenue estimate is $0 million. Over the last three months, EPS estimates have seen four upward revisions and eight downward revisions.

Impact on assets 1

Biotech & Genomic Medicine▲ · 1 stocks
© 2026 MarketIVNews